MIST
Milestone Pharmaceuticals Inc
NASDAQ: MIST · HEALTHCARE · BIOTECHNOLOGY
$1.80
-1.10% today
Updated 2026-04-30
Market cap
$218.86M
P/E ratio
—
P/S ratio
141.57x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$1 – $3
Volume
2.1M
Milestone Pharmaceuticals Inc (MIST) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $15.00M | $15.00M | $5.00M | $1.00M | $0.00 | $1.55M |
| Revenue growth (YoY) | — | — | — | — | +0.0% | -66.7% | -80.0% | -100.0% | — |
| Cost of revenue | $8000.00 | $10000.00 | $236000.00 | $376000.00 | — | $480000.00 | $598000.00 | $646000.00 | $114000.00 |
| Gross profit | $-8000.00 | $-10000.00 | $-236000.00 | $-376000.00 | $15.00M | $5.00M | $1.00M | $-646000.00 | $1.43M |
| Gross margin | — | — | — | -2.5% | 100.0% | 100.0% | 100.0% | — | 92.6% |
| R&D | $5.64M | $16.85M | $42.38M | $34.86M | $38.67M | $39.83M | $31.05M | $14.36M | $18.11M |
| SG&A | $1.50M | $3.05M | $6.73M | $9.97M | $12.40M | $15.72M | $15.93M | $16.74M | $17.27M |
| Operating income | $-8.27M | $-23.82M | $-57.88M | $-50.71M | $-43.07M | $-59.64M | $-61.10M | $-42.10M | $-62.48M |
| Operating margin | — | — | — | -338.1% | -287.2% | -1192.8% | -6109.8% | — | -4041.7% |
| EBITDA | $-8.26M | $-23.36M | $-57.84M | $-50.61M | $-42.98M | $-59.55M | $-57.04M | $-37.83M | $-62.14M |
| EBITDA margin | — | — | — | -337.4% | -286.5% | -1191.1% | -5703.9% | — | -4019.4% |
| EBIT | $-8.27M | $-23.37M | $-57.88M | $-50.71M | $-43.07M | $-59.64M | $-57.13M | $-37.94M | $-62.25M |
| Interest expense | $0.00 | $0.00 | $2.60M | $726000.00 | $220000.00 | $1.25M | $2.55M | $3.58M | $3.84M |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-8.09M | $-23.18M | $-55.23M | $-49.97M | $-42.85M | $-57.13M | $-59.69M | $-41.52M | $-63.06M |
| Net income growth (YoY) | — | -186.7% | -138.2% | +9.5% | +14.2% | -33.3% | -4.5% | +30.4% | -51.9% |
| Profit margin | — | — | — | -333.1% | -285.7% | -1142.7% | -5968.5% | — | -4078.8% |